Nelson Barton - SAN DIEGO CA, US David Weiner - Del Mar CA, US William Greenberg - San Diego CA, US Samantha Luu - San Diego CA, US Kristine Chang - San Diego CA, US Elizabeth Waters - San Diego CA, US
This invention provides amidases, polynucleotides encoding the amidases, methods of making and using these polynucleotides and polypeptides. In one aspect, the invention provides enzymes having secondary amidase activity, e.g., having activity in the hydrolysis of amides, including enzymes having peptidase, protease and/or hydantoinase activity. In alternative aspects, the enzymes of the invention can be used to used to increase flavor in food (e.g., enzyme ripened cheese), promote bacterial and fungal killing, modify and de-protect fine chemical intermediates, synthesize peptide bonds, carry out chiral resolutions, hydrolyze Cephalosporin C. The enzymes of the invention can be used to generate 7-aminocephalosporanic acid (7-ACA) and semi-synthetic cephalosporin antibiotics, including caphalothin, cephaloridine and cefuroxime. The enzymes of the invention can be used as antimicrobial agents, e.g., as cell wall hydrolytic agents. The invention also provides a fluorescent amidase substrate comprising 7-(ε-D-2-aminoadipoyladipoylamido)-4-methylcoumarin.
Glucosidases, Nucleic Acids Encoding Them And Methods For Making And Using Them
Kevin Gray - San Diego CA, US James Garrett - San Diego CA, US Nahla Aboushadi - Katy TX, US Ryan Knowles - Chula Vista CA, US Eileen O'Donoghue - San Diego CA, US Elizabeth Waters - San Diego CA, US
The invention is directed to polypeptides having a glucosidase activity, including an alpha-glucosidase activity, polynucleotides encoding the polypeptides, and methods for making and using these polynucleotides and polypeptides. In one aspect, the polypeptides of the invention are used as alpha-glucosidases to catalyze the hydrolysis of starch into sugars, e.g., to convert liquefied starch to glucose. In one aspect, the polypeptides of the invention can catalyze the hydrolysis of both alpha-(1,4) and alpha-(1,6) glucose linkages. In one aspect, the polypeptides of the invention can catalyze the hydrolysis of both malto-oligosaccharides and liquefied starch.
Nanoarchaeum Genome, Nanoarchaeum Polypeptides And Nucleic Acids Encoding Them And Methods For Making And Using Them
Karl O. Stetter - Regensubrg, DE Elizabeth Waters - San Diego CA, US Keith Kretz - San Marcos CA, US Mircea Podar - San Diego CA, US Toby Richardson - San Diego CA, US Michiel Noordewier - San Diego CA, US
The invention provides a genome of the hyperthermophile , polypeptides, including enzymes, structural protein and binding proteins, derived from this genome, polynucleotides encoding these polypeptides, methods of making and using these polynucleotides and polypeptides. The invention also provides isolated hyperthermophile
Enzymes Having Secondary Amidases Activity And Methods Of Use Thereof
Nelson Barton - San Diego CA, US David Weiner - Del Mar CA, US William Greenberg - San Diego CA, US Samantha Luu - San Diego CA, US Kristine Chang - San Diego CA, US Elizabeth Waters - San Diego CA, US
This invention provides amidases, polynucleotides encoding the amidases, methods of making and using these polynucleotides and polypeptides. In one aspect, the invention provides enzymes having secondary amidase activity, e.g., having activity in the hydrolysis of amides, including enzymes having peptidase, protease and/or hydantoinase activity. In alternative aspects, the enzymes of the invention can be used to used to increase flavor in food (e.g., enzyme ripened cheese), promote bacterial and fungal killing, modify and de-protect fine chemical intermediates, synthesize peptide bonds, carry out chiral resolutions, hydrolyze Cephalosporin C. The enzymes of the invention can be used to generate 7-aminocephalosporanic acid (7-ACA) and semi-synthetic cephalosporin antibiotics, including caphalothin, cephaloridine and cefuroxime. The enzymes of the invention can be used as antimicrobial agents, e.g., as cell wall hydrolytic agents. The invention also provides a fluorescent amidase substrate comprising 7-( -D-2-aminoadipoylamido)-4-methylcoumarin.
CONNECTIONS EDUCATION, INC Baltimore, MD Sep 2008 to Sep 2014 Vice President of Finance/Corporate ControllerFTI CONSULTING, INC Annapolis, MD Sep 2007 to Aug 2008 Director of Finance and Operations - Technology SegmentFTI Consulting, Inc. Annapolis, MD Jul 2003 to Aug 2007 Assistant Controller - CorporateNEXTEL COMMUNICATIONS, INC Reston, VA Jun 1996 to Jul 2003 Director of Financial Reporting and Technical AccountingAPPLIED BIOSCIENCE INTERNATIONAL INC Arlington, VA Oct 1993 to May 1996 Assistant ControllerARTHUR ANDERSEN & CO McLean, VA Dec 1986 to Oct 1993 Audit Manager
Education:
University of Maryland College Park, MD 1986 Bachelor of Science in Accounting
Children's Primary Care Medical GroupChildrens Primary Care Medical Group 292 Euclid Ave STE 220, San Diego, CA 92114 (619)2628624 (phone), (619)2626639 (fax)
Education:
Medical School Tufts University School of Medicine Graduated: 2009
Procedures:
Hearing Evaluation Psychological and Neuropsychological Tests Vaccine Administration
Dr. Waters graduated from the Tufts University School of Medicine in 2009. She works in San Diego, CA and specializes in Pediatrics. Dr. Waters is affiliated with Paradise Valley Hospital, Rady Childrens Hospital-San Diego, Sharp Chula Vista Medical Center and Sharp Memorial Hospital.
Elizabeth Waters, Chevy Chase MD - LICSW (Licensed Independent Clinical Social Worker)
Locke Hill Elementary School San Antonio TX 1986-1987, Kaiserslautern American Elementary School Kaiserslautern SC 1988-1994, Kaiserslautern American Junior High School Kaiserslautern SC 1993-1995
"Obesity prevention programs in general are not harming children," said lead author Elizabeth Waters, chair of child public health at the Melbourne School of Population Health. However, "programs that don't make a commitment to preventing body image issues might hurt children by stigmatizing overwei